Filing Details

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* AEHR TEST SYSTEMS ----------------------------------------------------------------------- (Name of Issuer) Common Stock ----------------------------------------------------------------------- (Title of Class of Securities) 00760J108 ----------------------------------------------------------------------- (CUSIP Number) Rhea J. Posedel C/O Aehr Test Systems 400 Kato Terrace Fremont, CA 94539 (510-623-9400) ----------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) April 19, 2017 ----------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of the Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box: / / Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 240.13d-7 for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Explanatory Note This Amendment No. 2 to the statement on Schedule 13D (the "Amendment No. 2") amends and supplements the Schedule 13D originally filed with the Securities and Exchange Commission (the "SEC") on February 13, 2015 (the "Statement"), by Rhea J. Posedel ("Mr. Posedel"), as further amended by the Amendment No. 1 filed on February 7, 2017 with respect to the common stock, par value $0.01 per share (the "Common Stock"), of Aehr Test Systems, a California corporation (the "Issuer"). Information reported in the Statement remains in effect except to the extent that it is amended, restated or superseded by information contained in this Amendment. The date of event which requires filing of this Amendment was due to the issuance of additional shares of Common Stock by the Issuer in a public offering transaction on April 19, 2017 as previously reported with the SEC on a Form 8-K filed on April 19, 2017 as the shares issued in the public offering subsequently reduced the percentage of Common Stock owned by Mr. Posedel. As of the date hereof, Mr. Posedel has ceased to be a beneficial owner of more than five percent of the class of securities, and the number of shares and percentage owned of Common Stock reported in this Amendment are as of the date of filing of this Amendment. Item 5 of the Statement is hereby amended and supplemented as follows: Item 5. Interest in Securities of the Issuer (a) The aggregate percentage of Common Stock reported to be owned by the Reporting Persons is based upon 21,394,152 shares of Common Stock outstanding, which is the total number of shares outstanding as of this filing date, and assumes the exercise of the 97,968 options held by Mr. Posedel which are exercisable within 60 days of this filing date. Mr. Posedel may be deemed to beneficially own in the aggregate 1,054,649 shares of Common Stock, representing approximately 4.9% of the outstanding shares of Common Stock. (b) Mr. Posedel owns 45,967 shares of Common Stock directly, and 97,968 options to purchase shares of Common stock which are exercisable within 60 days of this filing date. Rhea J. Posedel Family Trust, of which Mr. Posedel is Trustee, and has sole voting and dispositive power, owns 910,714 shares of Common Stock. (c) None. (d) No person other than Mr. Posedel, has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock set forth above. (e) Not applicable SIGNATURE After reasonable inquiry and to the best of each of the undersigned's knowledge and belief, each of the undersigned, severally and not jointly, certifies that the information set forth in this statement is true, complete and correct. Dated: April 27, 2017 RHEA J. POSEDEL. By: /S/ Rhea J. Posedel ------------------------ Name: Rhea J. Posedel Dated: April 27, 2017 Rhea J. Posedel Family Trust By: /S/ Rhea J. Posedel ----------------------------- Rhea J. Posedel ,Trustee